Whole Body and Regional Quantification of Active Human Brown Adipose Tissue Using 18F-FDG PET/CT
April 1st, 2019
10.7K views
Using free, open-source software, we have developed an analytical approach to quantify total and regional brown adipose tissue (BAT) volume and metabolic activity of BAT using 18F-FDG PET/CT.
Overview
This study presents a novel analytical approach for quantifying brown adipose tissue (BAT) volume and metabolic activity using 18 F-FDG PET/CT. The methodology aims to provide accurate measurements while minimizing false positives in BAT detection.
Key Study Components
Area of Science
- Neuroscience
- Metabolic Imaging
- Adipose Tissue Analysis
Background
- Brown adipose tissue plays a crucial role in thermogenesis and energy metabolism.
- Accurate quantification of BAT is essential for understanding metabolic health.
- Common imaging techniques often yield false positives in BAT identification.
- This study addresses these challenges with a refined methodology.
Purpose of Study
- To develop a reliable method for quantifying active BAT in human subjects.
- To reduce false positives in BAT detection.
- To provide detailed instructions for researchers on BAT classification.
Methods Used
- Utilization of 18 F-FDG PET/CT imaging.
- Step-by-step protocol for loading and editing PET-CT images.
- Implementation of specific criteria for BAT detection.
- In-depth anatomical guidance for accurate ROI drawing.
Main Results
- Successful identification and classification of metabolically active BAT deposits.
- Demonstrated reduction in false positives through refined ROI techniques.
- Comprehensive analysis of BAT across various anatomical regions.
- Enhanced understanding of regional BAT activation patterns.
Conclusions
- The developed methodology provides a robust framework for BAT quantification.
- Accurate BAT measurement can contribute to metabolic health research.
- Future studies can build on this approach to explore BAT's role in human metabolism.
Frequently Asked Questions
What is brown adipose tissue?
Brown adipose tissue is a type of fat tissue that generates heat by burning calories, playing a significant role in thermoregulation and energy metabolism.
How does the methodology reduce false positives?
The methodology incorporates specific criteria and anatomical landmarks to accurately identify and classify BAT, minimizing the risk of misidentification.
What imaging technique is used in this study?
The study utilizes 18 F-FDG PET/CT imaging to quantify brown adipose tissue volume and metabolic activity.
Why is accurate BAT quantification important?
Accurate BAT quantification is crucial for understanding its role in metabolic health and its potential implications for obesity and diabetes research.
Can this methodology be applied to other studies?
Yes, the methodology can be adapted for various studies focusing on metabolic health and adipose tissue analysis.
What are the main advantages of this approach?
The main advantages include reduced false positives, detailed anatomical guidance, and comprehensive analysis of BAT across different regions.
Executive Industry Relevance
Accurate quantification of metabolically active brown adipose tissue (BAT) supports target validation in metabolic disease research by enabling reliable assessment of thermogenic capacity. This method reduces false positives in BAT detection, improving predictive confidence in preclinical models of obesity and related disorders. Standardized regional analysis facilitates cross-functional collaboration and translational continuity from discovery to preclinical validation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses related to energy expenditure and thermogenesis.
- Operational Value: Provides quantitative BAT volume and activity metrics for target engagement assessment.
- Predictive Value: Supports biological de-risking by clarifying functional BAT distribution in human subjects.
Screening & Assay Development
- Scientific Value: Generates standardized, reproducible BAT measurements across anatomical regions for assay benchmarking.
- Operational Value: Establishes ROI-based protocols that improve consistency in longitudinal studies.
- Screening Readiness: Outputs volumetric and SUV-based readouts enabling reliable compound screening for metabolic modulators.
Translational & Preclinical Research
- Translational Continuity: Links in vitro findings to human BAT activation patterns via region-specific quantification.
- Preclinical Model Alignment: Supports disease-relevant system validation by comparing rodent and human BAT distribution.
- Risk-Adjusted Advancement: Informs go/no-go decisions based on BAT activation thresholds and regional specificity.
Pipeline & Workflow Integration
The method integrates into discovery biology through hypothesis-driven BAT activation studies, supports screening via quantitative metabolic readouts, and enables translational research by mapping active depots across human anatomy.
- Discovery Biology: Facilitates pathway clarification and target validation through precise BAT identification and exclusion of false positives.
- Screening: Delivers reproducible SUV-normalized measurements and volumetric outputs essential for evaluating metabolic modulators.
- Analytics: Provides region-specific activity metrics and distribution maps that support comparative condition analysis.
- Translational Research: Connects cellular mechanisms to human tissue-level responses via anatomical BAT mapping.
- Enterprise Reuse: Establishes a reusable imaging analysis framework applicable across metabolic disease programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing mechanistic ambiguity in BAT-mediated thermogenesis.
- Operational Value: Enhances standardization and reproducibility through landmark-guided ROI protocols.
- Strategic Value: Improves capital efficiency by enabling early de-risking of metabolic targets based on human BAT data.
- Portfolio Impact: Supports risk-adjusted prioritization of compounds targeting energy expenditure pathways.
Implementation Considerations
- Requires expertise in PET/CT imaging, anatomical landmark identification, and ROI segmentation techniques.
- Depends on access to PET/CT scanners, SUV calibration tools, and open-source image analysis software.
- Necessitates cross-team standardization between imaging, pharmacology, and data science groups for consistent BAT quantification.
- Involves adaptation considerations when applying the method across different subject cohorts or activation protocols.
- Limited by the time-intensive nature of manual ROI drawing, which may constrain scalability in high-throughput settings.
Biopharma FAQs
Why does SUV normalization matter for BAT target validation?
SUV normalization to lean body mass enables accurate comparison of BAT activity across subjects by accounting for individual metabolic variability, which is essential for reliable target engagement assessment in metabolic disease research.
How does excluding non-BAT tissues improve target confidence?
Excluding common false positives such as salivary glands and lymph nodes through combined PET/CT and anatomical criteria increases confidence that measured signal reflects true metabolically active BAT, reducing noise in target validation studies.
What quantitative outputs enable BAT screening readiness?
The method generates volumetric measurements and SUV-based activity readouts that provide quantifiable, reproducible endpoints for screening compounds intended to modulate BAT thermogenesis and energy expenditure.
Why do regional BAT distributions matter for cross-functional collaboration?
Mapping BAT activation across cervical, supraclavicular, axillary, and other regions allows imaging, pharmacology, and translational teams to align on biologically relevant depots, supporting consistent interpretation of target modulation across disciplines.
What statistical capabilities are needed before implementing BAT quantification?
Implementation requires the ability to analyze SUV thresholds, volumetric data, and regional distribution patterns using statistical tools that support comparison across conditions, subjects, or treatment groups to assess significant changes in BAT activity.
![Visualization and Quantification of Brown and Beige Adipose Tissues in Mice using [18F]FDG Micro-PET/MR Imaging](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62460.jpg%3Fv%3D2026-08-31T11%253A09%253A42.000Z&w=384&q=75)
![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg%3Fv%3D2026-08-26T02%253A14%253A49.000Z&w=384&q=75)
